| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |